Pietro Maffei

Pietro Maffei

Auto-generated profile, based on publicly available information

Pietro Maffei

Department of Medicine, Padua University, Padua, Italy

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2002 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
GCGayle B. Collin
Gayle B. Collin
JMJan D. Marshall
Jan D. Marshall
AIAkihiro Ikeda
Akihiro Ikeda
WSW. Venus So
W. Venus So
IRIsabelle Russell-Eggitt
Isabelle Russell-Eggitt
JNJürgen K. Naggert
Jürgen K. Naggert

13 October 2019 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
AGAndrea Giustina
Andrea Giustina
ABAriel Barkan
Ariel Barkan
ABAlbert Beckers
Albert Beckers
NBNienke Biermasz
Nienke Biermasz
BBBeverly M K Biller
Beverly M K Biller
SMShlomo Melmed
Shlomo Melmed
Objective: The aim of the Acromegaly Consensus Group was to revise and update the consensus on diagnosis and treatment of acromegaly comorbidities last published in 2013.Participants: The Consensus Group, convened by 11 Steering Committee members, consisted of 45 experts in the medical and surgical management of acromegaly. The authors received no corporate funding or remuneration.Evidence: This evidence-based consensus was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe both the strength of recommendations and the quality of evidence following critical discussion of the current literature on the diagnosis and treatment of acromegaly comorbidities.Consensus Process: Acromegaly Consensus Group participants conducted comprehensive literature searches for English-language papers on selected topics, reviewed brief presentations on each topic, and discussed current practice and recommendations in breakout groups. Consensus recommendations were developed based on all presentations and discussions. Members of the Scientific Committee graded the quality of the supporting evidence and the consensus recommendations using the GRADE system.Conclusions: Evidence-based approach consensus recommendations address important clinical issues regarding multidisciplinary management of acromegaly-related cardiovascular, endocrine, metabolic, and oncologic comorbidities, sleep apnea, and bone and joint disorders and their sequelae, as well as their effects on quality of life and mortality.

28 March 2005 in Archives of internal medicine (1960)
Verified
Journal Article
Open access
PDF file
JMJan D. Marshall
Jan D. Marshall
RBRoderick T. Bronson
Roderick T. Bronson
GCGayle B. Collin
Gayle B. Collin
ANAnne D. Nordstrom
Anne D. Nordstrom
PMPietro Maffei
Pietro Maffei
PNPatsy M. Nishina
Patsy M. Nishina
Alström syndrome (Online Mendelian Inheritance in Man [OMIM] 203800) is a rare (approximately 300 cases known) autosomal recessively inherited disorder that affects multiple organ systems.1-3 Patients develop early retinal pigmentary degeneration that leads to blindness and sensorineural hearing deficits. Metabolic disturbances begin in childhood and include severe insulin resistance; hyperinsulinemia; type 2 diabetes mellitus, truncal obesity; hypogonadism in males; hypertriglyceridemia; hypothyroidism; accelerated skeletal maturity that results in short stature, scoliosis, or kyphosis; and low growth hormone levels. Multiple organ failure, including dilated cardiomyopathy (DCM) and congestive heart failure (CHF), and hepatic or renal failure may occur. Clinical expression, onset, rate of progression, and severity of most of the features are variable, even within sibships.4 Delayed diagnosis and misdiagnosis are common, making estimates of the incidence of Alström syndrome difficult.5

1 May 2011 in Current Genomics
Verified
Journal Article
Open access
PDF file
JMJan D. Marshall
Jan D. Marshall
PMPietro Maffei
Pietro Maffei
GCGayle B. Collin
Gayle B. Collin
JNJurgen K. Naggert
Jurgen K. Naggert
Alstrom syndrome is a rare autosomal recessive genetic disorder characterized by cone-rod dystrophy, hearing loss, childhood truncal obesity, insulin resistance and hyperinsulinemia, type 2 diabetes, hypertriglyceridemia, short stature in adulthood, cardiomyopathy, and progressive pulmonary, hepatic, and renal dysfunction. Symptoms first appear in infancy and progressive development of multi-organ pathology leads to a reduced life expectancy. Variability in age of onset and severity of clinical symptoms, even within families, is likely due to genetic background. Alstrom syndrome is caused by mutations in ALMS1, a large gene comprised of 23 exons and coding for a protein of 4,169 amino acids. In general, ALMS1 gene defects include insertions, deletions, and nonsense mutations leading to protein truncations and found primarily in exons 8, 10 and 16. Multiple alternate splice forms exist. ALMS1 protein is found in centrosomes, basal bodies, and cytosol of all tissues affected by the disease. The identification of ALMS1 as a ciliary protein explains the range of observed phenotypes and their similarity to those of other ciliopathies such as Bardet- Biedl syndrome. Studies involving murine and cellular models of Alström syndrome have provided insight into the pathogenic mechanisms underlying obesity and type 2 diabetes, and other clinical problems. Ultimately, research into the pathogenesis of Alstrom syndrome should lead to better management and treatments for individuals, and have potentially important ramifications for other rare ciliopathies, as well as more common causes of obesity and diabetes, and other conditions common in the general population.

17 October 2007 in European Journal of Human Genetics
Verified
Journal Article
Closed access
JMJan D Marshall
Jan D Marshall
SBSebastian Beck
Sebastian Beck
PMPietro Maffei
Pietro Maffei
JNJürgen K Naggert
Jürgen K Naggert

2 April 2015 in Human Mutation
Verified
Journal Article
Closed access
PDF file
JMJan D. Marshall
Jan D. Marshall
JMJean Muller
Jean Muller
GCGayle B. Collin
Gayle B. Collin
GMGabriella Milan
Gabriella Milan
SKStephen F. Kingsmore
Stephen F. Kingsmore
JNJürgen K. Naggert
Jürgen K. Naggert